January 24th, 2011

AHA Estimates Cost of Heart Disease Will Triple by 2030

The American Heart Association (AHA) is projecting that the cost to treat heart disease in the U.S. will triple by 2030, from $273 billion today to $818 billion. The AHA policy statement is published in Circulation. The AHA estimates that the incidence of stroke and heart failure will each  grow by about 25% by 2030.

“These estimates don’t assume that we will continue to make new discoveries to reduce heart disease,” said Paul Heidenreich, chair of the AHA expert panel issuing the statement, in a press release. “If our ability to prevent and treat heart disease stays where we are right now, costs will triple in 20 years just through demographic changes in the population.”

3 Responses to “AHA Estimates Cost of Heart Disease Will Triple by 2030”

  1. These demographics and estimates create additional urgency that people take personal responsibility for their health and begin improving their lifestyle with clean eating and exercise. More primordial prevention, and the arguments about statin side effects, the cholesterol hypothesis and wars, etc. would abate. I gues then it would be more diet books and exercise DVDs though…
    Richard Kones

  2. Over technology dependency & inappropriate relation between Physician & Pharma Industry will fuel the predicted problem. Proper emphasis on Preventive Cardiology & mass awareness campaign on healthy lifestyle could reduce the cost.

  3. Robin Motz, M.D., Ph.D. says:

    The cost of treating heart disease would explode if we did a stress-thallium study on every male and every diabetic at the age of 40, and cathed those with positive or equivocal results. As I recall, not only do at least 10% of these patients have coronary atherosclerosis at autopsy ( and a 10% disease incidence is quite high), but autopsies of 19 year old soldiers during the Korean War already showed atherotic streaks in their aortas.